Search Results - mong-heng+wang

2 Results

Sort By:

The use of EETs blocker or antagonists to enhance the efficacy of AT1 blocker to treat diabetic retinopathy.

The use of EETs Blocker or Antagonists to Enhance the Efficacy of AT1 blocker to Treat Diabetic Retinopathy Application: Diabetic Retinopathy (DR) Advantages/Benefits: • This technology in combination with AT1 receptor blockade prevents and reduces DR • This technology can address the 33% of the U.S. population predicted...

Published: 11/23/2021 | Inventor(s): Mong-Heng Wang, Mohamed Al-Shabrawey

Keywords(s):

Category(s): Therapeutics

Use of 20-HETE blocker to eliminate stroke side effects and increase anti-tumor efficacy of rofecoxib (Vioxx) in colorectal cancer prevention

Current State of the Art: Surgery, radiation, and chemotherapy are three primary modes of treatment available for colorectal cancer (CRC). Although different treatment options are available, the mortality rate in case of CRC is the second highest among other forms of cancer. Early detection and chemical prevention are two major strategies adopted to...

Published: 3/31/2022 | Inventor(s): Mong-Heng Wang

Keywords(s):

Category(s): Therapeutics